Sandison Taylor

Avg. Two Year Performance

(73%) Avg. Purchase Return
(31%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return23%19%35%(5%)(73%)
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Cidara Therapeutics, Inc.

Drugs » Biotechnology

Chief Medical Officer:

Holdings: 23.07K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--